Form 7 Monthly Progress Report June 2023
Form 7 Monthly Progress Report May 2023 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 July 2, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to […]
Form 7 Monthly Progress Report May 2023
Form 7 Monthly Progress Report May 2023 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 June 2, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to […]
Form 7 Monthly Progress Report April 2023
Form 7 Monthly Progress Report March 2023 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 May 2, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to […]
Form 7 Monthly Progress Report March 2023
Form 7 Monthly Progress Report March 2023 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 April 2, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to […]
Indigenous Innovator: Dr. Nadine Caron’s Quest for Equity in Cancer Care and Research
Indigenous Innovator: Dr. Nadine Caron’s Quest for Equity in Cancer Care and Research Written by Tom Raycove, CEO Disrupted Logic Interactive Inc. Black History Month and Its Role in Understanding the Experiences of Indigenous Peoples Black History Month is a time to celebrate the contributions and achievements of black people, but it is also an […]
Form 7 Monthly Progress Report February 2023
Form 7 Monthly Progress Report February 2023 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 March 2, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to […]
Revolutionizing Cancer Research: Meet Dr. Juliet Daniel, the Trailblazing Black Scientist Making a Difference in the Lives of Triple Negative Breast Cancer (TNBC) Patients
Revolutionizing Cancer Research: Meet Dr. Juliet Daniel, the Trailblazing Black Scientist Making a Difference in the Lives of Triple Negative Breast Cancer (TNBC) Patients Written by Tom Raycove, CEO Disrupted Logic Interactive Inc. Celebrating Black History Month, we shine a spotlight on Dr. Juliet Daniel, a trailblazer in the field of cancer research. Driven by […]
Breaking Barriers – Past and Current: Celebrating the Legacy of Dr. Clarice Reid, Pioneer in Sickle Cell Research, Biomark Diagnostics
Breaking Barriers Past: Celebrating the Legacy of Dr. Clarice Reid, Pioneer in Sickle Cell Research Current: BioMark Diagnostics Inc. Pioneering Early Stage Cancer Detection Written by Tom Raycove, CEO Disrupted Logic Interactive Inc. Dr. Clarice Reid: Pioneering Work in the Field of Sickle Cell Disease Dr. Clarice Reid was a trailblazer in the field of […]
Form 7 Monthly Progress Report January 1 2023
Form 7 Monthly Progress Report February 1 2023 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 February 1, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended […]
Form 7 Monthly Progress Report December 1 2022
Form 7 Monthly Progress Report November 1 2022 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 January 4, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended […]
